Invizius' Unattributed VC Round

Invizius raised a round of funding on May 02, 2018. Investors include Mercia Fund Managers.

Invizius is advaincing a solution to reduce the risk of cardiovascular disease among patients undergoing long-term dialysis. Its H-Guard product is an anti-inflammatory used as a 'primer' to coat the …

Articles about Invizius' Unattributed VC Round: